Viewing nowCombinationLowstar Tablet 40/5 mg
Telmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Telcon RF Pharmaceutical Co., Ltd.

MFDS item code 201905277 · Approved 2019.07.24 · Insurance code 625500990
Treatment of essential hypertension not controlled with monotherapy
Essential hypertension refers to a condition where blood pressure is persistently high, and additional treatment may be required when blood pressure is not adequately controlled by monotherapy with amlodipine or telmisartan. In this case, combining the two medications helps to effectively lower and control blood pressure. By controlling hypertension, the burden on the heart and blood vessels is reduced, and the risk of complications such as stroke or myocardial infarction is lowered. Therefore, this medication is used for the treatment of essential hypertension, contributing to blood pressure improvement and cardiovascular health maintenance.
The recommended dose of this medicine is 1 tablet once daily, taken with water, with or without food. It is recommended that it be taken at the same time each day, if possible (e.g., in the morning). Before starting this medicine, it is recommended that the dose be adjusted using the individual components (amlodipine or telmisartan). However, if blood pressure is not adequately controlled with an individual component, switching directly to this medicine may be considered as follows: - 40/5 milligrams : For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or telmisartan 40 milligrams. - 80/5 milligrams : For patients whose blood pressure is not adequately controlled with amlodipine 5 milligrams or this medicine 40/5 milligrams. - 40/10 milligrams : For patients whose blood pressure is not adequately controlled with amlodipine 10 milligrams. Patients taking telmisartan and amlodipine concomitantly may switch to this medicine (a combination product containing the same amounts of each active ingredient) for convenience (limited to this medicine 40/5 milligrams). ○ Patients with renal impairment : No dose adjustment is necessary in patients with mild or moderate renal impairment. In patients with severe renal impairment, however, it is recommended to start treatment at a low dose and increase the dose gradually. Periodic monitoring of serum potassium and creatinine levels is also recommended. Telmisartan is not removed by hemodialysis. ○ Patients with hepatic impairment : The daily dose of telmisartan should not exceed 40 milligrams in patients with mild or moderate hepatic impairment. ◦ Elderly patients : The usual amlodipine dosage regimen is recommended for elderly patients, but caution should be exercised when increasing the dose (see section '3. Patients Requiring Caution'). In patients aged 75 years or older, amlodipine clearance is reduced; start treatment at a low dose and increase the dose gradually.
Use of this medicine is not recommended in pediatric patients aged 18 years or younger because its safety and efficacy have not been established.
This medication can pose serious risks to the fetus if taken during pregnancy, especially in the second and third trimesters, so it should not be taken by pregnant women or women who may become pregnant. This medication should not be administered to patients with allergies to the active ingredient or related components, breastfeeding women, severely impaired liver function patients, and those with severe hypotension or significant cardiac diseases. Patients with primary aldosteronism, certain heart valve diseases, liver dysfunction, gastrointestinal diseases, renal vascular abnormalities, dialysis patients, and the elderly require special care when using this medication. Various side effects such as dizziness, peripheral edema, hypotension, palpitations, dyspepsia, skin rash may occur during the use of this medication; if symptoms are severe or unusual, immediate consultation with a healthcare professional is necessary. This medication should not be used during pregnancy, and if pregnancy is confirmed, it should be discontinued as soon as possible. Breastfeeding women are also advised not to take this medication. This medication may interact with other drugs; it is essential to inform healthcare professionals about any medications currently being taken, especially when used with potassium supplements, diuretics, specific antibiotics, anticoagulants, etc. While taking this medication for hypertension treatment, regular check-ups for blood pressure, kidney function, and electrolyte levels are recommended to ensure there are no abnormalities. This medication may cause drowsiness or dizziness; therefore, caution is needed when driving or operating hazardous machinery. In case of overdose, symptoms such as severe hypotension, tachycardia, dizziness, or renal failure may appear, requiring immediate hospital treatment. This medication is not recommended for children as safety and efficacy in pediatric patients have not been well established, and in the elderly, it should be used with dosage adjustment and caution. Store this medication in a place inaccessible to children, ensuring it does not become damp, and it is advisable to take it immediately after opening the package.
Not everyone experiences these, and they can vary from person to person.
This medication is sensitive to light, so it should be stored in an opaque container that does not permit light. Additionally, it should be kept at room temperature between 1°C and 30°C, not too cold or too hot.
It is a white and light gray, double convex, oval-shaped tablet.
30 tablets/PTP [(10 tablets/PTP X 3)]
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Telcon RF Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Dasan Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 334.72mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 6.935mg
Prescription medication · Combination
Vivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
Bivozon Pharmaceutical Co., Ltd.
CombinationTelmisartan Powder 23.9% 167.36mg · Amlodipine Besylate 13.87mg
Prescription medication · Combination
CMG Pharmaceutical Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.